Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
10 drugmakers team up to improve testing process
Yahoo/AP
Thu, 09/20/12 - 10:38 am
TransCelerate BioPharma
Pfizer
JNJ
Bristol-Myers Squibb
Eli Lilly
Abbott Laboratories
GSK
AstraZeneca
Sanofi
Boehringer Ingelheim
Genentech
Decoding Emerging Pharma Markets
Seeking Alpha
Tue, 09/18/12 - 11:53 am
emerging markets
Abbott Labs
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novartis
Pfizer
Sanofi
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
Seeking Alpha
Tue, 09/18/12 - 11:09 am
PDL Biopharma
Novartis
Seattle Genetics
Pfizer
JNJ
Eli Lilly
GSK
Bristol-Myers Squibb
Vical and Bristol-Myers Ink Deal
Yahoo/Zacks
Mon, 09/17/12 - 03:50 pm
Vical
Bristol-Myers Squibb
Vaxfectin
Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers of recklessness
Fierce Biotech
Mon, 09/17/12 - 12:04 pm
R&D
Bristol-Myers Squibb
hepatitis C
BMS-094
Vical's Vaxfectin Comes Alive
Seeking Alpha
Thu, 09/13/12 - 04:03 pm
Vaxfectin
Vical
Bristol-Myers Squibb
metastatic melanoma
Mylan Waits Patiently at the Bottom of the Patent Cliff
Motley Fool
Thu, 09/6/12 - 04:23 pm
patents
patent cliff
Mylan
Pfizer
Lipitor
Merck
Singulair
Plavix
Bristol-Myers Squibb
Eli Lilly: New Drug Nightmares Will Sink Stock In 2013
Seeking Alpha
Wed, 09/5/12 - 11:50 am
Eli Lilly
Teva Pharmaceuticals
Pfizer
Mylan
Bristol-Myers Squibb
Cashed Up Biotech Vanda Could Keep On Falling
Seeking Alpha
Wed, 09/5/12 - 10:44 am
Vanda
Eli Lilly
Novartis
Bristol-Myers Squibb
Takeda
CEO Gaffe of the Week: Bristol-Myers Squibb -- Again!
Motley Fool
Tue, 09/4/12 - 11:09 am
Lamberto Andreotti
Bristol-Myers Squibb
3 Things to Watch in the Pharmaceutical Sector Right Now
Motley Fool
Tue, 09/4/12 - 11:05 am
Amylin
Bristol-Myers Squibb
Arena Pharmaceuticals
Pfizer
The $47 Billion Hole in Pharma's Near-Term Future
Forbes
Tue, 09/4/12 - 10:53 am
Pfizer
Merck
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
emerging markets
generics
Generics Will Drive Mylan Higher By 2013
Seeking Alpha
Fri, 08/31/12 - 12:33 pm
Mylan
generics
Bristol-Myers Squibb
Merck
Pfizer
Teva Pharmaceuticals
Ariad Pharmaceuticals Gearing Up For Ponatinib's Approval
Seeking Alpha
Wed, 08/29/12 - 05:54 pm
Ariad Pharmaceuticals
Ponatinib
Pfizer
Bristol-Myers Squibb
Novartis
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wed, 08/29/12 - 12:21 pm
Big Pharma
Lipitor
Anacetrapib
Merck
Plavix
Pfizer
Bristol-Myers Squibb
PCSK9 inhibitor
Sanofi
Regeneron
darapladib
Roche
GSK
Synergy Acquires FV-100 from BMY
Yahoo/Zacks
Wed, 08/29/12 - 10:38 am
Bristol-Myers Squibb
FV-100
Synergy Pharmaceuticals
shingles
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tue, 08/28/12 - 10:54 am
Merck
Januvia
diabetes
AstraZeneca
Bristol-Myers Squibb
JNJ
Novartis
Sanofi
Takeda
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Mon, 08/27/12 - 05:27 pm
Amylin
M&A
Bristol-Myers Squibb
Merck
Eli Lilly
AstraZeneca
diabetes
Idenix Drops After FDA Puts Hold on Another Hepatitis Drug
Minyanville
Mon, 08/27/12 - 10:40 am
hepatitis C
Idenix
FDA
Bristol-Myers Squibb
IDX19368
IDX184
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »